Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07776314 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT07776314 · ClinicalTrials.gov record · last posted 2026-08-20

Are There Any Clinical Benefits to Screening for Late -Onset Gestational Diabetes Mellitus?"

Name: Are There Any Clinical Benefits to Screening for Late -Onset Gestational Diabetes Mellitus?" — clinical trial record (NCT07776314)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhaseNot specified

SponsorIzmir Ataturk Training and Research Hospital

Started2025-03-13

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This study aims to screen women who have a negative Gestational diabetes mellitus (GDM) result in routine screening tests or who have never had it with the Fasting Blood Glucose Test (FBG) at 32-34 weeks of gestation to diagnose late-onset GDM with routine FBG ≥5.1 mmol/L (92mg/dl) in fasting blood, and to investigate its connection with perinatal and maternal outcomes, hoping to inform about late-stage GDM.

Trial Details

NCT Number	NCT07776314
Lead Sponsor	Izmir Ataturk Training and Research Hospital
Conditions	Pregnancy in Diabetes, Pregnancy, Pregnancy Outcomes
Enrollment	128 participants
Start Date	2025-03-13
Primary Completion	2026-09-01 (estimated)
Study Completion	2026-11-10 (estimated)
Updated on ClinicalTrials.gov	2026-08-20